- Home
- CDE vs CERT Comparison
CDE vs CERT Comparison
Compare CDE & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDE
- CERT
- Stock Information
- Founded
- CDE 1928
- CERT 2008
- Country
- CDE United States
- CERT United States
- Employees
- CDE N/A
- CERT N/A
- Industry
- CDE Precious Metals
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- CDE Basic Materials
- CERT Technology
- Exchange
- CDE Nasdaq
- CERT Nasdaq
- Market Cap
- CDE 2.4B
- CERT 2.3B
- IPO Year
- CDE N/A
- CERT 2020
- Fundamental
- Price
- CDE $7.84
- CERT $11.98
- Analyst Decision
- CDE Strong Buy
- CERT Buy
- Analyst Count
- CDE 4
- CERT 6
- Target Price
- CDE $8.00
- CERT $15.60
- AVG Volume (30 Days)
- CDE 16.6M
- CERT 2.8M
- Earning Date
- CDE 05-07-2025
- CERT 05-05-2025
- Dividend Yield
- CDE N/A
- CERT N/A
- EPS Growth
- CDE N/A
- CERT N/A
- EPS
- CDE 0.27
- CERT N/A
- Revenue
- CDE $1,201,008,000.00
- CERT $394,498,000.00
- Revenue This Year
- CDE $53.22
- CERT $11.41
- Revenue Next Year
- CDE $7.37
- CERT $8.78
- P/E Ratio
- CDE $28.58
- CERT N/A
- Revenue Growth
- CDE 41.80
- CERT 9.37
- 52 Week Low
- CDE $4.57
- CERT $8.64
- 52 Week High
- CDE $7.72
- CERT $17.94
- Technical
- Relative Strength Index (RSI)
- CDE 75.04
- CERT 45.14
- Support Level
- CDE $5.21
- CERT $11.22
- Resistance Level
- CDE $5.51
- CERT $12.30
- Average True Range (ATR)
- CDE 0.35
- CERT 0.68
- MACD
- CDE 0.19
- CERT -0.32
- Stochastic Oscillator
- CDE 99.43
- CERT 18.37
About CDE Coeur Mining Inc.
Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada Mexico, and North America.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.